SEC Form 4 · accession 0001638727-15-000005

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President

Period of report

Mar 26, 2015

Accepted (ET)

Dec 18, 2015 · 6:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares^F1	Dec 16, 2015	A	55,000	—	A	605,000	I	Private holding company
Common Shares	holding	—	—		—	550,000	I	Private holding company

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options^F1,F2	$0.09	Dec 16, 2015	A	50,000	A	Mar 26, 2015	Mar 26, 2020	Common Shares	50,000	550,000	D
Warrants^F1,F2	$0.23	Dec 16, 2015	A	13,000	A	May 15, 2015	May 15, 2017	Common Shares	13,000	143,000	I
Stock Options^F2	$0.09	holding	—	—	—	Mar 26, 2015	Mar 26, 2020	Common Shares	500,000	500,000	D
Warrants^F2	$0.23	holding	—	—	—	May 15, 2015	May 15, 2017	Common Shares	130,000	130,000	I